Loading...
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Apixaban is an oral, direct factor Xa inhibitor that inhibits both free and clot-bound factor Xa, and has been approved for clinical use in several thromboembolic disorders, including reduction of stroke risk in non-valvular atrial fibrillation, thromboprophylaxis following hip or knee replacement s...
Na minha lista:
| Udgivet i: | Clin Pharmacokinet |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769096/ https://ncbi.nlm.nih.gov/pubmed/31089975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-019-00775-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|